|
EUROPE |
PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN EUROPE
2016 (or latest year available)
|
Country / Territory |
Source |
Treatment |
Distribution of main drugs in percentages* |
Treatment |
Data |
||||||
|
Cannabis |
Cocaine |
ATS |
Tranquilizers |
Hallucinogens |
Solvents |
Other † |
|||||
|
Albania |
ARQ |
2015 |
23.5% |
33.1% |
0.4% |
1.5% |
0.0% |
0.0% |
0.0% |
472 |
|
|
Andorra |
ARQ |
2016 |
50.7% |
15.0% |
2.9% |
20.0% |
0.0% |
0.0% |
0.0% |
140 |
k |
|
Austria |
ARQ |
2015 |
24.2% |
5.9% |
4.5% |
2.1% |
0.1% |
0.0% |
0.2% |
4,400 |
a, e, f |
|
Belarus |
ARQ |
2016 |
|
|
|
|
|
|
|
14,000 |
|
|
Belgium |
ARQ |
2015 |
31.2% |
19.4% |
11.3% |
9.5% |
0.3% |
0.1% |
0.0% |
12,922 |
a |
|
Bosnia and Herzegovina |
ARQ |
2010-2015 |
4.4% |
0.0% |
0.8% |
0.3% |
0.3% |
0.0% |
0.0% |
455 |
j |
|
Bulgaria |
ARQ |
2015 |
5.7% |
2.1% |
8.6% |
3.3% |
0.1% |
0.1% |
2.2% |
7,070 |
a, k |
|
Croatia |
ARQ |
2016 |
17.4% |
1.3% |
2.2% |
2.3% |
0.2% |
0.1% |
3.1% |
7,202 |
|
|
Cyprus |
ARQ |
2015 |
58.1% |
9.1% |
4.1% |
0.4% |
0.1% |
0.0% |
0.2% |
1,304 |
c, e, f, h |
|
Czechia |
ARQ |
2015 |
9.6% |
0.2% |
44.8% |
1.7% |
0.1% |
0.1% |
|
5,874 |
a |
|
Denmark |
ARQ |
2014 |
70.9% |
5.5% |
6.9% |
1.4% |
0.1% |
0.1% |
2.0% |
4,705 |
e, f |
|
Estonia |
ARQ |
2016 |
1.2% |
0.3% |
4.3% |
0.3% |
0.3% |
0.0% |
0.0% |
346 |
e, f |
|
Finland |
EMCDDA |
2015 |
20.7% |
0.0% |
18.1% |
8.4% |
0.5% |
0.2% |
0.5% |
656 |
|
|
France |
ARQ |
2014 |
48.1% |
6.8% |
1.1% |
3.0% |
0.4% |
0.1% |
1.1% |
116,263 |
j |
|
Germany |
ARQ |
2015 |
41.0% |
6.0% |
17.2% |
0.0% |
0.2% |
0.1% |
3.2% |
83,617 |
a, k |
|
Gibraltar |
ARQ |
2008 |
23.8% |
66.7% |
0.0% |
4.8% |
0.0% |
0.0% |
0.0% |
41 |
d |
|
Greece |
ARQ |
2015 |
4.7% |
1.7% |
0.1% |
0.6% |
0.1% |
|
|
12,997 |
a |
|
Macedonia (TFYR) |
ARQ |
2009 |
6.8% |
1.3% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,212 |
|
|
Hungary |
ARQ |
2016 |
56.7% |
2.7% |
18.9% |
3.5% |
4.6% |
0.4% |
8.3% |
4,098 |
a |
|
Iceland |
ARQ |
2007 |
33.3% |
16.7% |
50.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,800 |
a |
|
Ireland |
ARQ |
2015 |
28.2% |
10.4% |
1.2% |
10.4% |
0.1% |
0.2% |
0.9% |
9,892 |
k, c |
|
Italy |
ARQ |
2016 |
11.1% |
17.8% |
0.3% |
0.4% |
0.1% |
0.0% |
0.6% |
143,273 |
c |
|
Latvia |
ARQ |
2016 |
22.1% |
0.7% |
16.4% |
5.9% |
0.3% |
2.8% |
1.1% |
879 |
|
|
Liechtenstein |
ARQ |
2016 |
|
|
|
|
|
|
|
31 |
a, d |
|
Lithuania |
ARQ |
2016 |
2.0% |
0.1% |
2.9% |
1.7% |
0.0% |
1.9% |
16.0% |
5,259 |
|
|
Luxembourg |
ARQ |
2015 |
|
|
|
|
|
|
|
1,200 |
a, h |
|
Malta |
ARQ |
2015 |
8.6% |
15.4% |
1.4% |
0.1% |
0.1% |
0.2% |
3.4% |
1,829 |
a |
|
Moldova (Republic of) |
ARQ |
2011/ 2013*** |
64.7% |
0.0% |
1.3% |
0.2% |
0.0% |
0.3% |
0.0% |
1,053 |
|
|
Monaco |
ARQ |
2013 |
83.9% |
1.8% |
0.0% |
5.4% |
0.0% |
1.8% |
0.0% |
56 |
|
|
Montenegro |
ARQ |
2015 |
0.0% |
0.5% |
0.0% |
3.6% |
0.0% |
0.0% |
0.0% |
670 |
b |
|
Netherlands |
ARQ |
2015 |
34.8% |
23.4% |
6.2% |
4.5% |
0.0% |
|
0.1% |
31,115 |
a, e, f, l |
|
Norway |
ARQ/Govt. |
2015 |
19.8% |
0.8% |
9.9% |
6.9% |
0.2% |
0.0% |
|
17,925 |
a, c |
|
Poland |
ARQ |
2015 |
28.0% |
2.1% |
36.2% |
3.9% |
0.2% |
0.3% |
0.3% |
9,013 |
|
|
Portugal |
ARQ |
2015 |
32.4% |
11.1% |
0.4% |
0.7% |
0.1% |
0.0% |
|
3,295 |
|
|
Romania |
ARQ |
2016 |
48.5% |
1.0% |
1.2% |
1.4% |
0.1% |
1.1% |
19.6% |
3,544 |
a |
|
Russian Federation |
ARQ |
2016 |
5.7% |
0.0% |
2.9% |
|
|
4.5% |
9.3% |
496,000 |
a |
|
Serbia |
ARQ |
2016 |
2.0% |
0.4% |
0.4% |
5.2% |
0.3% |
0.1% |
|
1,432 |
|
|
Slovakia |
ARQ |
2016 |
22.7% |
1.1% |
38.1% |
3.3% |
0.0% |
1.4% |
6.7% |
3,253 |
|
|
Slovenia |
ARQ |
2015 |
8.3% |
2.5% |
0.6% |
8.6% |
0.0% |
0.0% |
|
2,907 |
k, e, f, |
|
Spain |
ARQ |
2015 |
33.2% |
36.7% |
2.0% |
2.3% |
0.0% |
0.0% |
0.2% |
47,308 |
|
|
Sweden |
ARQ |
2015 |
13.7% |
1.1% |
8.0% |
17.2% |
1.0% |
0.3% |
|
24,488 |
|
|
Switzerland |
2014 |
33.2% |
11.5% |
2.9% |
2.3% |
0.3% |
|
0.8% |
3,194 |
k |
|
|
Turkey |
ARQ |
2015 |
6.0% |
1.8% |
2.8% |
0.6% |
0.3% |
1.6% |
12.7% |
10,884 |
d |
|
Ukraine |
ARQ |
2015 |
|
|
|
|
|
|
|
51,939 |
j |
|
United Kingdom |
ARQ |
2015 |
24.8% |
11.8% |
4.8% |
2.8% |
0.3% |
0.2% |
0.3% |
101,919 |
a |
|
Total |
|
|
|
|
|
|
|
1,251,932 |
|
||
|
Average |
26.0% |
8.4% |
8.2% |
3.8% |
0.3% |
0.5% |
2.7% |
|
|
||
|
EE&SEE |
16.8% |
3.8% |
1.9% |
1.8% |
0.1% |
0.7% |
4.7% |
595,933 |
|
||
|
WE&CE |
29.4% |
10.1% |
10.5% |
4.4% |
0.3% |
0.4% |
1.9% |
655,999 |
|
||
* Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 per cent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs. In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.
** Figures may reflect number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine.
*** If multiple years are given, the second year specified is for the number of people treated (second to last column).
† In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.
- Whole country
- Geographically limited reporting (eg the Capital city)
- Publicly funded treatment
- NGO/ privately funded treatment
- Inpatient/ hospitalization modality
- Outpatient modality
- Limited subpopulation (eg prison, youth, etc)
- Opioid substitution treatment (eg methadone)
- First-time treatment entrants (not returning clients)
- Treatment admissions (not persons)
- Partial coverage (geographical/treatment type)
- Prisons excluded
- Treatment entrants only